TN SB0422AI summary is being generated. Check back soon for a plain-language breakdown of this bill.
Positive media analysis is being generated.
Critical media analysis is being generated.
The analysis of SB0422, which pertains to the regulation of medical devices, reveals no direct conflicts of interest between the sponsor, Shane Reeves, and the bill's subject matter. While Reeves is the CEO of Twelve Stone Health Partners and has a background in pharmacology, the bill does not directly impact his business interests or personal financial gain. The advisory committee's review of medical device regulations may indirectly relate to his professional background, but there is no evidence to suggest that the bill would provide him with a financial benefit or advantage in his role as a pharmacy owner or CEO.
Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.
| Type | Description | Industry | Source |
|---|---|---|---|
| Employer | TWELVE STONE HEALTH PARTNERS | — | TN Ethics Commission |
| Business Owner | TWELVE STONE HEALTH PARTNERS CEO from Jan 2016 to Apr 2025 | — | TN Ethics Commission |
| Asset | 529 (AMERICAN FUNDS) | — | TN Ethics Commission |
| Occupation | Pharmacology, OWN A PHARMACY | — | TN Ethics Commission |
| Asset | Leadership PAC: REEVES FAMILY PAC | — | TN Ethics Commission |
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.
